Tricida, Inc. (TCDA)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
-94.62% vs
Rating Accuracy
0% (0 of 1*)
FV Performance
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+282.0%
*There is a current rating on the stock that is included in these numbers based on its performance so far
About
CEO
Gerrit Klaerner
Employees
119
Industry
Urology Biopharmaceuticals
Sector
Healthcare
Headquarters
South San Francisco
Exchange
NASDAQ
Website
http://www.tricida.comSummary Stats
Market Cap
13.7M
Revenue
-
Net Income
-
EPS
$0.00
Price-to-Earnings
-
Price-to-Book
-
Debt-to-Equity
-
News
Analyst Ratings
Price targets projected by 4 analysts
High
$20.00
Average
$13.00
Low
$6.00
Ratings calculated by 0 analysts
Buy
0
Hold
0
Sell
0
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q3 2022
Above by $0.11
-$0.43 +20.4%
-0.54
-0.61
Up 29%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--